DocCheck Stock

DocCheck ROCE

The Return on Capital Employed (ROCE) of DocCheck (AJ91.DE) as of Jul 26, 2026 is 18.28 %. In the previous year, Return on Capital Employed (ROCE) was 16.13 % — a change of 13.34% (higher).

ROCE

18.28 %

YoY

13.34%

Last updated:

In 2026, DocCheck's return on capital employed (ROCE) was 18.28 %, a 13.34% increase from the 16.13 % ROCE in the previous year.

Access this data via the Eulerpool API

DocCheck Stock analysis

What does DocCheck do? DocCheck AG is a German company that was established in Cologne in 1996. It is the largest European specialist portal for medical professionals and provides various products and services for doctors, pharmacists, and pharmaceutical professionals. Initially, the company focused primarily on offering continuing education for doctors and job placement in the medical field. However, soon the business model expanded and additional sectors were added. An important pillar of the company is the online portal DocCheck.com. Here, medical professionals can register and gain access to exclusive content including specialized articles, studies, and videos, as well as receive updates and news from the medical field. Additionally, the company offers a wide range of medical workwear and accessories. The products range from disposable gloves to stethoscopes and medical torches. The assortment is regularly updated and expanded. Another important area of focus is job placement in the medical sector. DocCheck is one of the largest providers on the German market for medical job advertisements. Employers can place ads for a fee, and job seekers can find suitable job offers. A special highlight for customers is the so-called DocCheck Flexikon. It is an online lexicon for medical terms, continuously revised and updated by specialists. The Flexikon is also available as a smartphone and tablet app. Overall, DocCheck is a company with a wide range of products and services tailored to the needs of medical professionals. In recent years, the company has become an important partner in the healthcare sector in Germany and Europe, and it has become an essential player in the industry. DocCheck is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling DocCheck's Return on Capital Employed (ROCE)

DocCheck's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing DocCheck's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

DocCheck's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in DocCheck’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about DocCheck stock

Return on Capital Employed (ROCE) of DocCheck is 18.28 % in 2026.

Access this data via the Eulerpool API

Profitability — DocCheck

All Key Metrics — DocCheck